Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture

• Main Authors: Charlotte Falaise, Cyrille François, Marie-Agnès Travers, Benjamin Morga, Joël Haure, Réjean Tremblay, François Turcotte, Pamela Pasetto, Romain Gastineau, Yann Hardivillier, Vincent Leignel, Jean-Luc Mouget
• Format: Article
• Language: English
• Published: MDPI AG 2016-09-01
• Series: Marine Drugs
• Subjects: biological activity; antimicrobial; antibacterial; antifungal; antiviral; Haslea; microalgae; sustainable aquaculture
• Online Access: http://www.mdpi.com/1660-3397/14/9/159

The search for novel compounds of marine origin has increased in the last decades for their application in various areas such as pharmaceutical, human or animal nutrition, cosmetics or bioenergy. In this context of blue technology development, microalgae are of particular interest due to their immense biodiversity and their relatively simple growth needs. In this review, we discuss about the promising use of microalgae and microalgal compounds as sources of natural antibiotics against human pathogens but also about their potential to limit microbial infections in aquaculture. An alternative to conventional antibiotics is needed as the microbial resistance to these drugs is increasing in humans and animals. Furthermore, using natural antibiotics for livestock could meet the consumer demand to avoid chemicals in food, would support a sustainable aquaculture and present the advantage of being environmentally friendly. Using natural and renewable microalgal compounds is still in its early days, but considering the important research development and rapid improvement in culture, extraction and purification processes, the valorization of microalgae will surely extend in the future.